- What are the top holdings of PBE?
- Invesco Biotechnology & Genome ETF holds 31 securities in total. The largest positions and their portfolio weights are listed on the Holdings tab.
- How many holdings does PBE have?
- PBE holds 31 positions as reported by the fund's most recent disclosure.
- What sectors does PBE invest in?
- Invesco Biotechnology & Genome ETF (PBE) allocates across the sectors shown above. The largest exposure tops the list; the rest follow in descending weight order.
- What sector is PBE most exposed to?
- PBE's full sector breakdown is on the Sectors tab. The largest sector weight is shown there along with the rest of the allocation.
- Is PBE a US-only fund?
- The country allocation card on this page shows PBE's geographic exposure. Funds with > 95% US weight are effectively US-only; international or global funds will show meaningful weights across multiple countries.
- What does PBE invest in?
- The Invesco Biotechnology & Genome ETF (PBE) seeks to replicate the performance of the Dynamic Biotech & Genome Intellidex Index. This fund typically allocates a minimum of 90% of its total assets to the securities comprising the underlying index. The Index is constructed to achieve capital appreciation by thoroughly evaluating companies based on several investment criteria, including their price momentum, earnings growth, overall quality, management decisions, and valuation. It consists of 30 U.S.-based companies within the biotechnology and genome sectors. These companies are primarily involved in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, or they are businesses that stand to gain significantly from scientific and technological breakthroughs in biotechnology and genetic engineering. Both the ETF and its benchmark index undergo quarterly rebalancing and reconstitution in February, May, August, and November.
